Damien Brunet

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Johanne Silvain, Benoît Lattuca, Farzin Beygui et al. · The Lancet · 2020 · 122 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +10

Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score

Vincent Auffret, Yves Cottin, Guillaume Leurent et al. · European Heart Journal · 2018 · 106 citations

N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Samuel Goussot, Christiane Mousson, Charles Guénancia et al. · The American Journal of Cardiology · 2015 · 35 citations

Percutaneous Coronary Intervention, Cardiovascular Translational Research, Contrast-induced Nephropathy +12

Pre-Infarction Angina and Outcomes in Non-ST-Segment Elevation Myocardial Infarction: Data from the RICO Survey

Luc Lorgis, Aurélie Gudjoncik, Carole Richard et al. · PLoS ONE · 2012 · 29 citations · Full text

Early improvement of left ventricular function after implantation of a transcutaneous aortic valve: A tissue Doppler ultrasound study

Fabrice Bauer, Sandra Bénigno, M Lemercier et al. · Archives of cardiovascular diseases · 2009 · 17 citations

Heart Failure, Transcutaneous Aortic Valve, Medicine +11